版本:
中国

BRIEF-Spring Bank Pharmaceuticals provides update on sting platform

June 7 Spring Bank Pharmaceuticals Inc

* Spring Bank provides update on its next-generation sting platform and announces publication of an abstract at ASCO related to its lead sting agonist candidate, SB 11285

* Spring Bank is advancing development of SB 11285 with plan to initiate its first clinical trial in 2018 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐